This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Bill Gates Gets In On 'Nerd Facebook'

NEW YORK ( TheStreet) -- When I first heard about ResearchGate, the German social network start-up aimed at scientists, my first reaction was "Cool. Nerd Facebook."

Well, guess how you can connect with ResearchGate, right through the home page? Facebook (FB).

Beyond using the larger company's database to expand their own reach, however, the two companies have little in common. Anyone can join Facebook. ResearchGate members have to be vetted through the publication of papers.

ResearchGate is newsworthy today because Bill Gates joined its latest $35 million Series C funding round, alongside Tenaya Capital and two other funds, according to TechCrunch .


Competitor Academia.edu, which also coordinates data through Facebook, actually has more members, almost 3.4 million, against ResearchGate's 2.9 million, but it has only gone through a Series A funding round of $4.5 million. Both companies prefer to be compared with LinkedIn (LNKD).


The two also define their markets somewhat differently -- Academia.edu encourages the sharing of raw data and is open to all academics, while ResearchGate claims it already has half the world's scientific researchers on its membership roles.

What's most exciting is how sites like ResearchGate encourage global collaboration among members. Two examples from today's news:

  1. ReadWrite noted the grad student in the Phillippines who posted his failed formula for getting energy from waste oil on the site, then a Spanish scientist found a tweak that made the formula work.
  2. AllThingD writes about how an Italian researcher with equipment but no samples met a Nigerian with samples but no equipment on the site, and how they've published papers about a new, deadly form of yeast on ResearchGate itself.

This kind of collaboration has awesome potential for commercial researchers, who can scour the site for fresh perspectives and relevant data. ResearchGate's business model is to build marketplaces for people and equipment. Business can help by using the site to help find employees, and by trading esoteric gear there.

But the more important point about these sites is they get researchers out of their "silos," the narrow fields they spend their days studying, to see if there's something they're missing in the larger scientific community.

This is precisely how my alma mater, Rice University in Houston, came to be a research power in the 1980s. It had people in disparate fields collaborate because there just weren't many people on the campus, but it found the cross-fertilization worked wonders in enhancing discovery.


The point for Gates, and for some of the other big-name backers of ResearchGate, is to reduce friction among researchers, encourage collaboration and speed breakthroughs. The old world of peer-reviewed research that costs thousands to publish and access is giving way to a more open and collaborative process.

Whether this model can get its discoveries through the maze of "intellectual property" laws and into the market is still open to debate.


At the time of publication the author had no position in any of the stocks mentioned.

This article was written by an independent contributor, separate from TheStreet's regular news coverage.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
AAPL $126.41 0.00%
FB $81.21 0.00%
GOOG $575.33 0.00%
TSLA $200.63 0.00%
YHOO $44.16 0.00%

Markets

DOW 18,135.72 +38.82 0.21%
S&P 500 2,101.04 +2.51 0.12%
NASDAQ 4,982.8090 +15.6680 0.32%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs